
GNPX
Healthcare · Biotechnology · $1.7M market cap
$2.08-0.13 (-5.9%)Nov 13, 4:00 PM EST
Latest report
Time not confirmed
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Jun 30, 2025
EPS trend, 90 days to now · +33.9% over 90 days · 30-day revisions 1 up, 0 down
Beat estimates in 0 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 13, 2026 | Time not confirmed | — | — | — |
| Aug 14, 2026 | Time not confirmed | — | -9.40 | — |
| Jun 3, 2026 | Time not confirmed | — | -14.12 | — |
| Mar 27, 2026 | Time not confirmed | — | -25.33 | — |
| Nov 14, 2025 | Time not confirmed | -0.65 | -5.00 | -669.2% |
| Aug 14, 2025 | Time not confirmed | -0.74 | -8.47 | -1044.6% |
| Mar 31, 2025 | After the close | -0.39 | -0.42 | -8.8% |
| Nov 13, 2024 | Before the open | -3003.00 | -1353.00 | +54.9% |
| Aug 9, 2024 | After the close | -2530.00 | -3300.00 | -30.4% |
| May 15, 2024 | After the close | -2794.00 | -4059.00 | -45.3% |
| Feb 26, 2024 | After the close | -3.93 | -3.96 | -0.8% |
| Nov 14, 2023 | After the close | -0.11 | -0.13 | -18.2% |
| Aug 21, 2023 | After the close | -0.12 |
Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. The company's technologies are designed to administer disease-fighting genes to provide new therapies for patient populations with cancer and diabetes. Its oncology program utilizes its systemic, non-viral Oncoprex Delivery System, which encapsulates the gene-expressing plasmids using…
| -0.15 |
| -25.0% |
| May 22, 2023 | After the close | -0.12 | -0.19 | -58.3% |
| Mar 31, 2023 | After the close | -6600.01 | -6600.01 | 0.0% |
| Nov 14, 2022 | Before the open | -5280.01 | -5720.01 | -8.3% |
| Aug 12, 2022 | After the close | -5280.01 | -4840.00 | +8.3% |
| May 13, 2022 | After the close | -5280.01 | -5280.01 | 0.0% |
| Mar 30, 2022 | After the close | -0.09 | -0.12 | -33.3% |
| Nov 15, 2021 | Before the open | -4840.00 | -3080.00 | +36.4% |
| Aug 13, 2021 | After the close | -5720.01 | -3520.00 | +38.5% |
| May 17, 2021 | Before the open | -5280.01 | -6160.01 | -16.7% |
| Mar 26, 2021 | After the close | -0.28 | -0.14 | +50.0% |
| Nov 12, 2020 | After the close | -9240.01 | -3080.00 | +66.7% |
| Aug 11, 2020 | After the close | -8360.01 | -5280.01 | +36.8% |
| May 14, 2020 | After the close | -3520.00 | -8800.01 | -150.0% |
| Nov 14, 2019 | After the close | -0.22 | -0.15 | +31.8% |
| Aug 13, 2019 | After the close | -0.21 | -0.24 | -14.3% |
| May 15, 2019 | After the close | -9240.01 | -6160.01 | +33.3% |
| Mar 29, 2019 | Time not confirmed | -0.14 | -8.00 | -5614.3% |
| Nov 14, 2018 | After the close | -5720.01 | -6600.01 | -15.4% |
| Aug 14, 2018 | Before the open | -0.17 | -0.31 | -82.4% |
| May 15, 2018 | After the close | — | -0.05 | — |